Who is eligible for this vaccination: Everybody who is over 6 months old and wish to be vaccinated against A(H1N1) 2009 pandemic virus, including foreigners permanently living in Mongolia could be vaccinated.

Which vaccine is to be used? The brand name of vaccine is “Arepanrix”. This is an inactivated vaccine prepared from A/California/7/2009(H1N1) pandemic influenza virus produced by Glaxo-Smith-Klein, Canada. It is used as an intra-muscular injection of 0.25 ml for children up to 9 years old and of 0.5 ml for children and adults over 9 years old. The vaccine is capable induce life-long immunity against the A/California/7/2009(H1N1) virus and will offer 30%-70% cross-protection against other A(H1N1) virus variants.

Are there some contra-indications against the vaccine? Yes. The contra-indications are:

• Elevated sensitivity to eggs, chicken proteins, allergic background to formaldehyde, mercury containing preparations and some antibiotics;
• Early stage of pregnancy (till 20th week of gravidity);
• Patients with fever and other signs of acute infections;
• Chronic patients using immunosuppressive and cytostatic medicines have to be vaccinated only on the permission of their doctors.

Which reactions and complications may be observed after the vaccination? It has been observed some reactions, like subfebrility, head-ache, myalgies, pain and swelling on the site of injection etc which was disappeared within 1-2 days without specific treatment. It has not been registered life-threatening complications so far. If the named signs persist more than 2 days or will be expressed too intense it is better to seek doctor’s advice.

Where’s the vaccination site? It is offered by the Voluntary Vaccination Site in the Outpatient Clinic (Building 2a) of the National Center of Communicable Diseases NCCD (Pls refer the attached road-map of NCCD)

Working hours of the vaccination site: 9:00-12:00 am in the weekdays (from Monday to Friday).

Phones for reference: 45-17-98 (Vaccination Service, NCCD for Mongolian speakers); 9988-1381 (Dr G.Suren-khand, MD, Deputy Director, NCCD for English speakers); NCCD